Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU [Phase 3]
A Phase 3 trial evaluating bevacizumab in metastatic breast cancer that overexpresses HER-2/neu was terminated, and results have been posted…
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: Breast MRI Spectroscopy [NA]
Completed clinical trial update on breast MRI spectroscopy for suspected or known breast cancer.
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: Rural Women Connecting for Better Health [NA]
This Clinical Trial Update reports that the Rural Women Connecting for Better Health study, sponsored by the University of Kansas Medical Ce…
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: Effectiveness of Acupuncture for Breast Cancer Related Lymphedema [NA]
An update on a clinical trial evaluating acupuncture for breast cancer-related lymphedema; no results are provided in the available data.
-
CLINICAL_TRIALS trial_result · 2016-11-22Clinical Trial Update: A Study to Assess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer [Phase 2]
Phase 2 trial evaluating the efficacy and safety of combining pertuzumab with trastuzumab and vinorelbine in HER2-positive breast cancer; re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-22Clinical Trial Update: A Study of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Advanced and/or Metastatic Breast Cancer [Phase 2]
A Phase 2 study of Herceptin (trastuzumab) in women with HER2-positive advanced or metastatic breast cancer has completed enrollment and pos…
-
CLINICAL_TRIALS research · 2016-11-22Clinical Trial Update: Phase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in Humans [Phase 1]
Phase I imaging trial evaluating 68Ga-NODAGA-E(cRGDyK)2 PET for assessing angiogenesis in primary and metastatic tumors; trial status is unk…
-
CLINICAL_TRIALS trial_result · 2016-11-22Clinical Trial Update: Neoadjuvant Treatment of Docetaxel, Anthracycline and Cyclophosphamide (TAC) Versus Docetaxel and Cyclophosphamide (TC) in Triple-Negative or Her2 Positive Breast Cancer [Phase 3]
Phase 3 neoadjuvant trial comparing TAC (docetaxel, doxorubicin, cyclophosphamide) versus TC (docetaxel and cyclophosphamide) in triple-nega…
-
CLINICAL_TRIALS trial_result · 2016-11-22Clinical Trial Update: IORT (Intra-operative Radiation Therapy) in Early Stage Breast Cancer [NA]
A clinical trial update notes that the NCT01988870 study evaluating intraoperative radiotherapy for early-stage breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: Pilot 3D Mammography Reader Study to Assess Breast Cancer Detection in 3D Versus 2D Digital Mammography
This is a completed pilot study comparing 3D mammography with 2D digital mammography for breast cancer detection. It evaluates the diagnosti…
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: The Efficacy of Acupuncture in Treating Chemotherapy Side Effects in Breast Cancer Patients [NA]
A clinical trial evaluating acupuncture for chemotherapy side effects in breast cancer patients was terminated; results were posted in Novem…
-
CLINICAL_TRIALS research · 2016-11-18Clinical Trial Update: A Phase 2 Randomized, Double-blind Trial Evaluating the Effects of Chloroquine in Breast Cancer [Phase 2]
Clinical trial update for a Phase 2 randomized, double-blind study of chloroquine in breast cancer (invasive) with unknown status.
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Pre-Surgery Positron Emission Mammography in Patients With Newly Diagnosed Breast Cancer [NA]
This entry notes that a clinical trial evaluating pre-surgery positron emission mammography in women with newly diagnosed breast cancer has …
-
CLINICAL_TRIALS trial_result · 2016-11-17Clinical Trial Update: Neoadjuvant Tamoxifen in Locally Advanced Breast Cancer in a Low/Middle Income Country [Phase 2]
Phase 2 trial evaluating neoadjuvant tamoxifen for locally advanced breast cancer in a low/middle-income country has completed with results …
-
CLINICAL_TRIALS trial_result · 2016-11-17Clinical Trial Update: Evaluation of a Breast Biblock Analgesia for the Mastectomy With Radical Axillary Lymphadenectomy Surgery
A completed clinical trial evaluating a breast biblock analgesia technique for pain management during mastectomy with radical axillary lymph…
-
FDA approval · 2016-11-17FDA Approved: GEMCITABINE — Supplemental Application (Hospira, Inc.)
FDA approved Hospira, Inc.'s supplemental application for gemcitabine under ANDA 079183. This represents approval of a supplemental submissi…
-
CLINICAL_TRIALS research · 2016-11-17Clinical Trial Update: Breast Cancer Molecular Analysis Protocol
Clinical trial update reporting a molecular analysis protocol for metastatic breast cancer, with the sponsor Yale University noting the stud…
-
CLINICAL_TRIALS trial_result · 2016-11-15Clinical Trial Update: Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer [Phase 3]
A Phase 3 trial evaluating the addition of trastuzumab to standard combination chemotherapy in women with breast cancer; results have been p…
-
CLINICAL_TRIALS trial_result · 2016-11-15Clinical Trial Update: A Study of Whole Brain Radiation Therapy and Capecitabine in Breast Cancer Participants With Newly Diagnosed Brain Metastasis [Phase 2]
This update reports the termination of a Phase 2 study evaluating whole brain radiation therapy in combination with capecitabine for breast …
-
CLINICAL_TRIALS withdrawal · 2016-11-15Clinical Trial Update: Reirradiation With Concurrent Paclitaxel for Breast Cancer [Phase 1]
This Phase 1 trial assessing reirradiation with concurrent paclitaxel for breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-11-15Clinical Trial Update: Intervention to Improve Self-Care of Symptoms in Breast Cancer Survivors on Adjuvant Endocrine Therapy [NA]
A clinical trial titled "Intervention to Improve Self-Care of Symptoms in Breast Cancer Survivors on Adjuvant Endocrine Therapy" has been wi…
-
CLINICAL_TRIALS withdrawal · 2016-11-15Clinical Trial Update: Fatigue in Breast Cancer Patients Undergoing Radiotherapy-eSMART-MH [NA]
The clinical trial NCT02759549 investigating fatigue in breast cancer patients undergoing radiotherapy (eSMART-MH) has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-11-15Clinical Trial Update: Multiple Oncological Serial Scans Study [NA]
The clinical trial 'Multiple Oncological Serial Scans Study' focusing on breast cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-11-10Clinical Trial Update: Nodal Staging in Breast Cancer With MRL [NA]
Clinical trial NCT01609920 studying nodal staging in breast cancer with MRL has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: Patient Factors Impacting Adherence to Oral Chemotherapy
A completed clinical trial from Memorial Sloan Kettering Cancer Center evaluating how patient factors influence adherence to oral chemothera…